FUSIONCX vs SICAGEN: Stock Comparison
FUSION CX is the larger company by market capitalisation. SICAGEN INDIA shows a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FUSIONCX leads 0; SICAGEN leads 2 of 4
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | FUSIONCX | SICAGEN |
|---|---|---|
| Live Price | ₹270.7 | ₹55.28 |
| Day Change | -2.7% | -3.15% |
| Volume | 99,038 | 11,971 |
| 52-Week High | ₹312.95 | ₹74.06 |
| 52-Week Low | ₹262.3 | ₹46.55 |
| Distance from 52W High | -13.5% | -25.36% |
Valuation
| Metric | FUSIONCX | SICAGEN |
|---|---|---|
| Market Cap | ₹3,925 Cr | ₹218 Cr |
| P/E Ratio | — | 11.41x |
| P/B Ratio | — | 0.47x |
| EPS | — | ₹1.75 |
| Book Value | — | ₹125.09 |
| Dividend Yield | 0% | 1.81% |
Growth
| Metric | FUSIONCX | SICAGEN |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | — | 2.9% |
| Qtr Profit Growth | — | 55.38% |
Profitability & Leverage
| Metric | FUSIONCX | SICAGEN |
|---|---|---|
| ROE | — | 3.65% |
| ROCE | — | 4.43% |
| Net Margin | 0% | 1.86% |
| Operating Margin | — | 3.9% |
| Debt to Equity | — | 0.29x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | FUSIONCX | SICAGEN |
|---|---|---|
| Promoter Holding | — | 23.92% |
| FII Holding | — | 2.47% |
| DII Holding | — | 0.58% |
| Public Holding | — | 35.81% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FUSION CX and SICAGEN INDIA.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.